Abstract
Allergic rhinitis has been one of the major allergic diseases in Otorhinolaryngology.
Currently basic therapeutic approaches to the allergic rhinitis are to avoid allergen, to control a responsible environment and desensitize patients if possible.
Yet, these are not final solution to the allergic rhinitis. Anti-allergic agents have maintained their places for this reason, though effects are known to be quite transient.
Incidal, anti-histamine agent, was tried for the allergy and results were presented.
Incidal was administered to 43 patients suffering from the allergic rhinitis. Six tablets of Incidal a day were prescribed for 7 days and its effects was interpreted in a week following t h e last Incidal administration. By maxillary mucosal tests performed radiologically, 74.4% of the patients treated were positive for intradermal a allergic tests and 46.2% revealed pathologic lesions in the maxillary sinuses (rest of 53.8% were normal).
The results demonstrated that Incidal was quite effective on 8 patients, effective on 2 3, a little effective on 9 and was not effective on 3. Therefore it implied percentage-wise that Incidal was found to be effective on 72%, a little effective on 20.9% and not effective on 7.0 % of the patients.
As for objective findings of the nose, no patient showed marked improvement, while one revealed some improvement and 9 resulted in fair responses.
Remaining 33 patients demonstrated no objective benifit what so ever. Neutophiles decreased in general during the treatments. Regarding side-actions, it showed no hypnotic effect but on one. Two patients complained GI tract disturbances.
In general, Incidal brought satisfactory results.
